Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR3C1 | P04150 | 15/20 | 0.51 |
| ▸ | PGR | P06401 | 14/20 | 0.51 |
| ▸ | NR3C2 | P08235 | 14/20 | 0.51 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.51 |
| ▸ | ASH1L | Q9NR48 | 5/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3773214 | 1.00 | NR3C1 (0.51) | NR3C1PGRNR3C2CYP3A4ASH1L | |
| SCHEMBL3773206 | 1.00 | NR3C1 (0.51) | NR3C1PGRNR3C2CYP3A4ASH1L | |
| SCHEMBL13010445 | 0.94 | NR3C1 (0.49) | NR3C1PGRNR3C2CYP3A4ASH1L | |
| SCHEMBL3777261 | 0.89 | NR3C1 (0.53) | NR3C1PGRNR3C2CYP3A4 | |
| SCHEMBL3642520 | 0.89 | NR3C1 (0.53) | NR3C1PGRNR3C2CYP3A4 | |
| SCHEMBL3772842 | 0.87 | NR3C1 (0.51) | NR3C1PGRNR3C2CYP3A4 | |
| SCHEMBL3781975 | 0.86 | NR3C1 (0.52) | NR3C1PGRNR3C2CYP3A4 | |
| SCHEMBL3781982 | 0.86 | NR3C1 (0.52) | NR3C1PGRNR3C2CYP3A4 | |
| SCHEMBL3781980 | 0.86 | NR3C1 (0.52) | NR3C1PGRNR3C2CYP3A4 | |
| SCHEMBL3642966 | 0.85 | NR3C1 (0.55) | NR3C1PGRNR3C2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100317863-A1 | Glucocorticoid Mimetics, Methods of Making Them, Pharmaceutical Compositions and Uses Thereof | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2010-12-16 | — | — | US | claimed |
| US-20100317863-A1 | Glucocorticoid Mimetics, Methods of Making Them, Pharmaceutical Compositions and Uses Thereof | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2010-12-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100317863-A1 | Glucocorticoid Mimetics, Methods of Making Them, Pharmaceutical Compositions and Uses Thereof | NR3C1, MC2R, NR3C2 | NR3C1 1/4885PGR 84/4885NR3C2 3/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.